Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...